Overview of Dr. Juloori
Dr. Aditya Juloori is a radiation oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Baylor College of Medicine and has been in practice 3 years. He is one of 33 doctors at University of Chicago Medical Center who specialize in Radiation Oncology. He has more than 40 publications and over 500 citings.
Office
5758 S. Maryland Ave.
Chicago, IL 60637- Is this information wrong?
Education & Training
Cleveland Clinic FoundationResidency, Radiation Oncology, 2014 - 2019
Baylor College of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2019 - 2026
OH State Medical License 2014 - 2019- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials.Connor Lynch, Mark C Korpics, Rohan R Katipally, Tianming Wu, Christine M Bestvina, Sean Pitroda, Steven J Chmura, Aditya Juloori> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
- 2 citationsOncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.Tasoulas, J., Tasoulas, J., Goodman, J. F., Goodman, J. F., Mukdad, L., Mirabelle Sajisevi, Kenny Nguyen, Peter Callas, Andrew J Holcomb, Emre Vural, Kyle P Davis, Car...> ;JAMA Otolaryngology-- Head & Neck Surgery. 2024 Feb 1
- Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.Rohan R Katipally, Liam F Spurr, Stanley I Gutiontov, William Tyler Turchan, Philip Connell, Aditya Juloori, Renuka Malik, Michael S Binkley, Alice L Jiang, Sherin J R...> ;JCO Precision Oncology. 2023 Jan 1
- Join now to see all
Journal Articles
- Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and ToxicityBrian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research
Press Mentions
Targeted Therapies + SRS Combo Prolongs Survival in Patients with Renal Cell Carcinoma Brain MetastasesSeptember 27th, 2017
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
